These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29213430)

  • 1. Risk factors for neurocognitive impairment in HIV-infected patients and comparison of different screening tools.
    de Souza EM; Buoniconti CS; Valim FC; Moura AS
    Dement Neuropsychol; 2016; 10(1):42-46. PubMed ID: 29213430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two screening tests for HIV-Associated Neurocognitive Disorder suspected Japanese patients with respect to cART usage.
    Kami-Onaga K; Tateyama M; Kinjo T; Parrott G; Tominaga D; Takahashi-Nakazato A; Nakamura H; Tasato D; Miyagi K; Maeda S; Arae H; Uehara H; Miyagi K; Haranaga S; Fujita J
    PLoS One; 2018; 13(6):e0199106. PubMed ID: 29902251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
    Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
    BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is International HIV Dementia Scale good enough to diagnose HIV-associated neurocognitive disorders?
    Himanshu D; Tandon R; Kumar S; Sawlani KK; Verma SK; Misra R; Atam V
    J Family Med Prim Care; 2022 Sep; 11(9):5060-5064. PubMed ID: 36505608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurocognitive impairment and characteristics of neurocognitive performance among people with HIV on antiretroviral treatment].
    Xia JJ; Wang SL; Hu YF; Shen WW; Lin HJ; Shi RZ; Ma ZH; Li ZH; Li SZ; Ding YY; Chen XX; He N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1651-1657. PubMed ID: 36456499
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment.
    Ding Y; Lin H; Shen W; Wu Q; Gao M; He N
    J Neuroimmune Pharmacol; 2017 Dec; 12(4):661-669. PubMed ID: 28470583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
    Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
    PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment.
    Aita SL; Kaewpoowat Q; Yasri S; Rerkasem A; Rerkasem K; Choovuthayakorn J; Ausayakhun S; Robertson K; Roth RM; Robbins NM
    J Neurovirol; 2021 Aug; 27(4):568-578. PubMed ID: 34185242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Minimental State Examination Scale and the International HIV Dementia Scale in Assessing Cognitive Function in Nigerian HIV Patients on Antiretroviral Therapy.
    Oshinaike OO; Akinbami AA; Ojo OO; Ojini IF; Okubadejo UN; Danesi AM
    AIDS Res Treat; 2012; 2012():581531. PubMed ID: 23050130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy.
    Skinner S; Adewale AJ; DeBlock L; Gill MJ; Power C
    HIV Med; 2009 Apr; 10(4):246-52. PubMed ID: 19187172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project.
    Ku NS; Lee Y; Ahn JY; Song JE; Kim MH; Kim SB; Jeong SJ; Hong KW; Kim E; Han SH; Song JY; Cheong HJ; Song YG; Kim WJ; Kim JM; Smith DM; Choi JY
    HIV Med; 2014 Sep; 15(8):470-7. PubMed ID: 24580888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.
    Joska JA; Witten J; Thomas KG; Robertson C; Casson-Crook M; Roosa H; Creighton J; Lyons J; McArthur J; Sacktor NC
    AIDS Behav; 2016 Aug; 20(8):1621-31. PubMed ID: 26860536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.
    Phillips NJ; Thomas KGF; Myer L; Sacktor N; Zar HJ; Stein DJ; Hoare J
    AIDS; 2019 Apr; 33(5):815-824. PubMed ID: 30649059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for HIV-Associated Neurocognitive Disorder (HAND) in Adults Aged 50 and Over Attending a Government HIV Clinic in Kilimanjaro, Tanzania. Comparison of the International HIV Dementia Scale (IHDS) and IDEA Six Item Dementia Screen.
    Kellett-Wright J; Flatt A; Eaton P; Urasa S; Howlett W; Dekker M; Kisoli A; Duijinmaijer A; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska E; Akinyemi R; Lwezuala B; Gray WK; Walker RW; Dotchin CL; Makupa P; Paddick SM
    AIDS Behav; 2021 Feb; 25(2):542-553. PubMed ID: 32875460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of a Short Neuropsychological Protocol for Detecting HIV-Associated Neurocognitive Disorders in Patients with Asymptomatic HIV-1 Infection.
    Martinez-Banfi M; Vélez JI; Mebarak Chams MR; Arcos-Holzinger M; Acosta-López JE; García R; Perea MV; Arcos-Burgos M; Ladera V
    Brain Sci; 2021 Aug; 11(8):. PubMed ID: 34439656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV-2 population.
    Almeida F; Macedo A; Trigo D; Abreu M; Guimarães M; Luís N; Pinho R; Tavares R
    HIV Med; 2021 Mar; 22(3):212-217. PubMed ID: 33012065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder.
    Molinaro M; Sacktor N; Nakigozi G; Anok A; Batte J; Kisakye A; Myanja R; Nakasujja N; Robertson KR; Gray RH; Wawer MJ; Saylor D
    J Acquir Immune Defic Syndr; 2020 Mar; 83(3):278-283. PubMed ID: 32032278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV.
    Trunfio M; De Francesco D; Vai D; Medina C; Milesi M; Domini S; Alcantarini C; Imperiale D; Bonora S; Di Perri G; Calcagno A
    AIDS Behav; 2022 Jul; 26(7):2203-2211. PubMed ID: 34982319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An exploratory study on the diagnostic cutoff value of International HIV-associated Dementia Scale in minority ethnic groups with different educational levels, in Guangxi].
    Zhao TT; Feng QM; Liang H; Tang XY; Wei B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Nov; 32(11):1101-4. PubMed ID: 22336543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding a brief self-report cognitive tool to the IHDS improves effectiveness of identifying patients with HIV-associated dementia in South Africa.
    Gouse H; Casson-Crook M; Decloedt EH; Joska JA; Thomas KGF
    J Neurovirol; 2017 Oct; 23(5):686-695. PubMed ID: 28748448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.